Recombinant DNA: how simple can we make it?

William of Ockham was a Franciscan friar famous for saying “More things should not be used than are necessary”. Inspired by this, we created SEGA that enables engineering of advanced genetic designs directly on the E. coli genome by simply adding DNA to a frozen stock of cells.
Recombinant DNA: how simple can we make it?
Like

Science can be complicated, which is perhaps why scientists have always been fascinated with simplicity. Famous examples include: “Simplicity is the ultimate sophistication” (Leonardo de Vinci), “Truth is ever to be found in the simplicity, and not in the multiplicity and confusion of things” (Isaac Newton) and “Everything should be made as simple as possible, but not simpler” (Albert Einstein).

Everyone who has tried working in a laboratory knows the pain of a failed or irreproducible experiment. Some even say that a field like synthetic biology is facing a reproducibility crisis.  One thing is for sure: a major bottleneck in biotechnology is the complexity of both biology and molecular biology protocols.

Two complementary ways to address these challenges is to introduce standards in molecular biology and to simplify the methods. With this mind, we created SEGA: the standardized genome architecture. With SEGA, recombining DNA doesn’t get any simpler: We just add DNA to cells! The DNA automatically integrates on the genome and successful recombinant clones are identified based on the color of the bacterial colonies.

Sounds cool, right? But surely this is not compatible with making advanced genetic constructs directly on the genome of E. coli? Wrong! This is where standards (and years of hard work in our lab) come into play. We generated more than hundred different “landing pads” on the genome hosting a variety of well-characterized genetic modules controlling transcription, translation, and down-streaming processing of your gene- or protein-of-interest. Everything is open source. The strains are available at the Belgian Co-ordinated Collections of Microorganisms (https://bccm.belspo.be), all sequences can be downloaded in Genbank format and SBOL format at https://synbiohub.org, and detailed protocols are available at protocols.io64.

Watch Carolyn explain more about SEGA here : https://sega-genomes.com & https://www.youtube.com/watch?v=ZnsXpZflOF4  

As a scientific principle, Ockham’s words are perhaps better known with slight modifications as Occam’s razor: “If two explanations are plausible, the simplest explanation, usually the one with the fewest assumptions, is preferred”. I like the other version better – it is simpler! And I think that the only necessary things for making recombinant DNA should be: DNA and cells.

Please sign in or register for FREE

If you are a registered user on Research Communities by Springer Nature, please sign in

Subscribe to the Topic

Biotechnology
Life Sciences > Biological Sciences > Biotechnology

Related Collections

With collections, you can get published faster and increase your visibility.

Pre-clinical drug discovery

We welcome studies reporting advances in the discovery, characterization and application of compounds active on biologically or industrially relevant targets. Examples include emerging screening technologies, the development of small bioactive compounds/peptides/proteins, and the elucidation of compound structure-activity relationships, target interactions and mechanism-of-action.

Publishing Model: Open Access

Deadline: Mar 31, 2024

Biomedical applications for nanotechnologies

Overall, there are still several challenges on the path to the clinical translation of nanomedicines, and we aim to bridge this gap by inviting submissions of articles that demonstrate the translational potential of nanomedicines with promising pre-clinical data.

Publishing Model: Open Access

Deadline: Dec 31, 2023